We studied the mechanism of hematopoietic suppression in aplastic anemia by means of two-color flow microfluorometric analysis of lymphocyte subpopulations and correlated the results with the occurrence in vitro of hematopoietic suppression and interferon production. In 12 patients with aplastic anemia a striking increase was observed in a population of "activated" suppressor T lymphocytes, which were defined by binding of both anti-Leu-2 and anti-HLA-DR monoclonal antibodies (patients with aplastic anemia, 6.8 +/- 3.2 per cent [mean +/- S.D.]; normal subjects, 1.7 +/- 1.3; patients given multiple transfusions, 2.5 +/- 1.7). Tac antigen expression, another surface marker of lymphocyte activation, was increased on suppressor lymphocytes in all five patients examined (patients with aplastic anemia, 31 +/- 17 per cent; normal subjects, 0.7 +/- 0.24; patients given multiple transfusions, 2.3 +/- 1.2). When Tac+ and Tac- cells were separated in a cell sorter, only Tac+ cells produced interferon. When lymphocytes of patients with aplastic anemia were cocultured with normal bone marrow, only the Tac+ cell fraction showed hematopoietic suppressor activity. In one patient, in vitro elimination of suppressor lymphocytes by use of OKT8 antibody abolished spontaneous interferon production by bone-marrow cells. These results suggest that activated suppressor lymphocytes producing interferon have a role in the pathogenesis of bone-marrow failure, and indicate the usefulness of defined lymphokine and phenotypic markers in the study of aplastic anemia.
This article has been cited by other articles:
Solomou, E. E., Gibellini, F., Stewart, B., Malide, D., Berg, M., Visconte, V., Green, S., Childs, R., Chanock, S. J., Young, N. S.
(2007). Perforin gene mutations in patients with acquired aplastic anemia. Blood
109: 5234-5237
[Abstract][Full Text]
Takamatsu, H., Feng, X., Chuhjo, T., Lu, X., Sugimori, C., Okawa, K., Yamamoto, M., Iseki, S., Nakao, S.
(2007). Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia. Blood
109: 2514-2520
[Abstract][Full Text]
Solomou, E. E., Keyvanfar, K., Young, N. S.
(2006). T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood
107: 3983-3991
[Abstract][Full Text]
Platanias, L. C.
(2006). Interferon-inducible genes and aplastic anemia. Blood
107: 2-3
[Full Text]
Katsoulidis, E., Li, Y., Yoon, P., Sassano, A., Altman, J., Kannan-Thulasiraman, P., Balasubramanian, L., Parmar, S., Varga, J., Tallman, M. S., Verma, A., Platanias, L. C.
(2005). Role of the p38 Mitogen-Activated Protein Kinase Pathway in Cytokine-Mediated Hematopoietic Suppression in Myelodysplastic Syndromes. Cancer Res.
65: 9029-9037
[Abstract][Full Text]
Feng, X., Chuhjo, T., Sugimori, C., Kotani, T., Lu, X., Takami, A., Takamatsu, H., Yamazaki, H., Nakao, S.
(2004). Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood
104: 2425-2431
[Abstract][Full Text]
Hirano, N., Butler, M. O., von Bergwelt-Baildon, M. S., Maecker, B., Schultze, J. L., O'Connor, K. C., Schur, P. H., Kojima, S., Guinan, E. C., Nadler, L. M.
(2003). Autoantibodies frequently detected in patients with aplastic anemia. Blood
102: 4567-4575
[Abstract][Full Text]
Kochenderfer, J. N., Kobayashi, S., Wieder, E. D., Su, C., Molldrem, J. J.
(2002). Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood
100: 3639-3645
[Abstract][Full Text]
Risitano, A. M., Kook, H., Zeng, W., Chen, G., Young, N. S., Maciejewski, J. P.
(2002). Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by Vbeta CDR3 spectratyping and flow cytometry. Blood
100: 178-183
[Abstract][Full Text]
Verma, A., Deb, D. K., Sassano, A., Kambhampati, S., Wickrema, A., Uddin, S., Mohindru, M., Van Besien, K., Platanias, L. C.
(2002). Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia. J. Immunol.
168: 5984-5988
[Abstract][Full Text]
Kook, H., Risitano, A. M., Zeng, W., Wlodarski, M., Lottemann, C., Nakamura, R., Barrett, J., Young, N. S., Maciejewski, J. P.
(2002). Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. Blood
99: 3668-3675
[Abstract][Full Text]
Brodsky, R. A., Sensenbrenner, L. L., Smith, B. D., Dorr, D., Seaman, P. J., Lee, S. M., Karp, J. E., Brodsky, I., Jones, R. J.
(2001). Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia. ANN INTERN MED
135: 477-483
[Abstract][Full Text]
Karadimitris, A., Manavalan, J. S., Thaler, H. T., Notaro, R., Araten, D. J., Nafa, K., Roberts, I. A.G., Weksler, M. E., Luzzatto, L.
(2000). Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood
96: 2613-2620
[Abstract][Full Text]
Young, N. S., Abkowitz, J. L., Luzzatto, L.
(2000). New Insights into the Pathophysiology of Acquired Cytopenias. ASH Education Book
2000: 18-38
[Abstract][Full Text]
Zeng, W., Nakao, S., Takamatsu, H., Yachie, A., Takami, A., Kondo, Y., Sugimori, N., Yamazaki, H., Miura, Y., Shiobara, S., Matsuda, T.
(1999). Characterization of T-Cell Repertoire of the Bone Marrow in Immune-Mediated Aplastic Anemia: Evidence for the Involvement of Antigen-Driven T-Cell Response in Cyclosporine-Dependent Aplastic Anemia. Blood
93: 3008-3016
[Abstract][Full Text]
Nakao, S., Takami, A., Takamatsu, H., Zeng, W., Sugimori, N., Yamazaki, H., Miura, Y., Ueda, M., Shiobara, S., Yoshioka, T., Kaneshige, T., Yasukawa, M., Matsuda, T.
(1997). Isolation of a T-Cell Clone Showing HLA-DRB1*0405-Restricted Cytotoxicity for Hematopoietic Cells in a Patient With Aplastic Anemia. Blood
89: 3691-3699
[Abstract][Full Text]
Brown, K. E., Tisdale, J., Barrett, A. J., Dunbar, C. E., Young, N. S.
(1997). Hepatitis-Associated Aplastic Anemia. NEJM
336: 1059-1064
[Abstract][Full Text]
Wolach, B., Choc, L., Pomeranz, A., Ari, Y. B., Douer, D., Metzker, A.
(1993). Aplastic Anemia in Neonatal Lupus Erythematosus. Arch Pediatr Adolesc Med
147: 941-944
[Abstract]
Hibbs, J. R., Frickhofen, N., Rosenfeld, S. J., Feinstone, S. M., Kojima, S., Bacigalupo, A., Locasciulli, A., Tzakis, A. G., Alter, H. J., Young, N. S.
(1992). Aplastic Anemia and Viral Hepatitis: Non-A, Non-B, Non-C?. JAMA
267: 2051-2054
[Abstract]
Rauch, A. E., Kowalsky, S. F., Lesar, T. S., Sauerbier, G. A., Burkart, P. T., Scharfman, W. B.
(1990). Lindane (Kwell) -Induced Aplastic Anemia. Arch Intern Med
150: 2393-2395
[Abstract]
Shannon, K., Koehne, W., Heyman, M. B., Koerper, M. A.
(1990). Relapsing Post-hepatitis Aplastic Anemia: Immunosuppressive Therapy. CLIN PEDIATR
29: 25-29
[Abstract]
Baranski, B., Armstrong, G., Truman, J. T., Quinnan, G. V. Jr, Straus, S. E., Young, N. S.
(1988). Epstein-Barr Virus in the Bone Marrow of Patients with Aplastic Anemia. ANN INTERN MED
109: 695-704
[Abstract]
BALABAN, E. P., SHEEHAN, R. G., LIPSKY, P. E., FRENKEL, E. P.
(1987). Treatment of Cutaneous Sclerosis and Aplastic Anemia with Antithymocyte Globulin. ANN INTERN MED
106: 56-58
[Abstract]
GREENE, W. C., LEONARD, W. J., DEPPER, J. M., NELSON, D. L., WALDMANN, T. A.
(1986). The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic Retroviruses. ANN INTERN MED
105: 560-572
[Abstract]
Chan, W. C., Winton, E. F., Waldmann, T. A.
(1986). Lymphocytosis of Large Granular Lymphocytes. Arch Intern Med
146: 1201-1203
[Abstract]
Waldmann, T.
(1986). The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science
232: 727-732
[Abstract]
BARTON, J. C., PRASTHOFER, E. F., EGAN, M. L., HECK, L. W. Jr., KOOPMAN, W. J., GROSSI, C. E.
(1986). Rheumatoid Arthritis Associated with Expanded Populations of Granular Lymphocytes. ANN INTERN MED
104: 314-323
[Abstract]
